ClearRead Xray - Detect

Riverain Technologies

ClearRead Detect identifies regions-of-interest on the bone suppressed soft tissue image that may be early-stage lung cancer.
Product specifications Information source: Vendor
Last updated: Feb. 22, 2021
General
Product name ClearRead Xray - Detect
Company Riverain Technologies
Subspeciality Chest
Modality X-ray
Disease targeted lung cancer
Key-features lung nodule detection
Suggested use
Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis
Processing time
Certification
CE
Certified, Class IIa
FDA
PMA approved, Class III
Market presence
On market since 11-2008
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Subscription, One-off payment with service contract
Based on Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers